1059 related articles for article (PubMed ID: 1968930)
41. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
[TBL] [Abstract][Full Text] [Related]
42. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
43. Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice.
Schirmbeck R; Zerrahn J; Kuhröber A; Kury E; Deppert W; Reimann J
Eur J Immunol; 1992 Mar; 22(3):759-66. PubMed ID: 1312473
[TBL] [Abstract][Full Text] [Related]
44. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
Ramos A; Merino R; Merino J
Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
[TBL] [Abstract][Full Text] [Related]
45. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
[TBL] [Abstract][Full Text] [Related]
46. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
Moser M; Sharrow SO; Shearer GM
J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
[TBL] [Abstract][Full Text] [Related]
47. Response to Listeria monocytogenes in mice lacking MHC class Ia molecules.
Seaman MS; Pérarnau B; Lindahl KF; Lemonnier FA; Forman J
J Immunol; 1999 May; 162(9):5429-36. PubMed ID: 10228021
[TBL] [Abstract][Full Text] [Related]
48. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
49. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
Lamousé-Smith E; Clements VK; Ostrand-Rosenberg S
J Immunol; 1993 Dec; 151(11):6283-90. PubMed ID: 8245467
[TBL] [Abstract][Full Text] [Related]
50. Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.
Ohlén C; Bastin J; Ljunggren HG; Foster L; Wolpert E; Klein G; Townsend AR; Kärre K
J Immunol; 1990 Jul; 145(1):52-8. PubMed ID: 2358681
[TBL] [Abstract][Full Text] [Related]
51. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
52. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
Whalen BJ; Tony HP; Parker DC
J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
[TBL] [Abstract][Full Text] [Related]
53. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
54. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
Boog CJ; Boes J; Melief CJ
Eur J Immunol; 1988 Feb; 18(2):219-23. PubMed ID: 2965021
[TBL] [Abstract][Full Text] [Related]
55. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
[TBL] [Abstract][Full Text] [Related]
56. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
Claesson MH; Rudolphi A; Tscherning T; Reimann J
Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
[TBL] [Abstract][Full Text] [Related]
57. In vivo functional clonal deletion of recipient CD4+ T helper precursor cells that can recognize class II MHC on injected donor lymphoid cells.
Kiziroglu F; Miller RG
J Immunol; 1991 Feb; 146(4):1104-12. PubMed ID: 1671401
[TBL] [Abstract][Full Text] [Related]
58. Cytotoxic T lymphocytes generated across and I-Ab mutant difference are directed against a molecule bearing Ia antigens.
de Waal LP; Melief CJ; Melvold RW
Eur J Immunol; 1981 Mar; 11(3):258-65. PubMed ID: 6165590
[TBL] [Abstract][Full Text] [Related]
59. Immune and non-immune factors in cryopreserved tissues.
Tomita Y; Yoshikawa M; Zhang Qi; Uchida T; Nakashima Y; Sueishi K; Nomoto K; Yasui H
J Heart Lung Transplant; 2003 May; 22(5):560-7. PubMed ID: 12742419
[TBL] [Abstract][Full Text] [Related]
60. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
